secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2026-02-20T23:59:59+00:00
Accession:  0001213900-26-018874
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea receives Nasdaq bid price deficiency notice; 180-day cure period
-------------------------------------------------------------------------

- Received Nasdaq notice on Feb 20, 2026 for failing minimum $1.00 bid price for 30 consecutive business days.
- Company has until August 19, 2026 to regain compliance; needs closing bid >=$1.00 for 10 consecutive days.
- If not cured, may qualify for additional 180 days if it meets other listing standards and considers reverse split.
- Notice does not affect business operations or SEC reporting; company evaluating options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390026018874/0001213900-26-018874-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390026018874/ea0277843-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-018874

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer